I saw the news before hours deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer . Unfortunately all of my funds were locked up in OTCs that are untradable before market hours. So I figured that I missed the boat on this one. I didn't consider, however, that in a market like this folks will jump all over this type of release. Now I see the stock at $.75 after hours and I could have bought four $.40 at the opening.
So we'll add this one to my personal wall of shame along with the two ten baggers WB (on the judgement day) and PDO that I also missed this year.
I guess the only way it go from here is down right?